Works matching IS 03407004 AND DT 2005 AND VI 54 AND IP 11
Results: 10
Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 11, p. 1137, doi. 10.1007/s00262-005-0703-4
- By:
- Publication type:
- Article
T cell-mediated graft-versus-leukemia reactions after allogeneic stem cell transplantation.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 11, p. 1043, doi. 10.1007/s00262-005-0681-6
- By:
- Publication type:
- Article
Tumor counterattack: fact or fiction?
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 11, p. 1127, doi. 10.1007/s00262-005-0680-7
- By:
- Publication type:
- Article
Induction of anti B-cell malignance CTL response by subfamily-shared peptides derived from variable domain of immunoglobulin heavy chain.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 11, p. 1106, doi. 10.1007/s00262-005-0696-z
- By:
- Publication type:
- Article
Low-dose IL-2 induces cytokine cascade, eosinophilia, and a transient Th2 shift in melanoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 11, p. 1095, doi. 10.1007/s00262-005-0701-6
- By:
- Publication type:
- Article
The interplay between innate and adaptive immunity regulates cancer development.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 11, p. 1143, doi. 10.1007/s00262-005-0702-5
- By:
- Publication type:
- Article
CD3 × CD28 cross-interacting bispecific antibodies improve tumor cell dependent T-cell activation.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 11, p. 1059, doi. 10.1007/s00262-005-0671-8
- By:
- Publication type:
- Article
Virulizin, a novel immunotherapy agent, activates NK cells through induction of IL-12 expression in macrophages.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 11, p. 1115, doi. 10.1007/s00262-005-0698-x
- By:
- Publication type:
- Article
Immune responses to p53 in patients with cancer:enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 11, p. 1072, doi. 10.1007/s00262-005-0670-9
- By:
- Publication type:
- Article
Induction of Th1-type immunity and tumor protection with a prostate-specific antigen DNA vaccine.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 11, p. 1082, doi. 10.1007/s00262-005-0687-0
- By:
- Publication type:
- Article